New search | Conferencedetail
Print view
 
 

Striving towards the elimination of HCV infection, Berlin 2018

EASL The Home of Hepatology
Conference themes
Globally, morbidity and mortality due to HCV infection continues to rise. However, the availability of simple and tolerable DAA therapies for HCV infection with cure rates >90% is one of the greatest medical advances in decades. This has brought considerable optimism to people working in HCV. The WHO has set an ambitious goal to eliminate HCV as a major public health threat by 2030.
Professional congress organizer (PCO)
evvnt Platform / evvnt
Notes
Url:

Booking: https://go.evvnt.com/147888-1

Speakers: Prof. Francesco Negro, Dr. Alessio Aghemo, Prof. Jason Grebely
 

Enquiries and Registration:

Mr. EASL The Home of Hepatology
 
Categories
General Medicine
Languages
English
Congress fees
EASL Member Early fee: EUR 300 EASL Member: EUR 450 Non Member Early fee: EUR 450 Non Member : EUR 550
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AGEM - Arbeitsgemeinschaft Ethnomedizin e. V.Center of ExcellenceÄrztekammer für WienEuropean Health Forum GasteinÖsterreichisches Rotes KreuzÖsterreichische Gesellschaft für Public HealthFFG - 7. EU-RahmenprogrammCharité International Academy

Facebook

Give us your professional opinion

Start survey

Start survey